Panmira Pharmaceuticals, LLC

Amira Pharmaceuticals, Inc.

Thomas Jonathan Seiders

John Howard Hutchinson

Brian Andrew Stearns

Bowei Wang

Jeannie M Arruda

Yen Truong

Jill Melissa Scott

Described herein are compounds that are antagonists of PGDreceptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGDreceptors described herein, as well as methods of using such antagonists of PGDreceptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD-dependent or PGD-mediated conditions or diseases.

[object Object]

Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.

Tricyclic inhibitors of 5-lipoxygenase

Growing community of inventors

San Diego, CA, United States of America

Thomas Jonathan Seiders